EORTC-22962-ROG

A phase III study comparing conventional versus hyperfractionated radiotherapy, with or without concomitant chemotherapy, in patients with head and neck squamous cell carcinoma.
Trial StatusAll trial activities ended
DatesDate of activation: 16-Dec-96
Closed on : 30-Apr-99
Data management at EORTCFull
Phase3
Randomized trialYes
Type-
Targeted Sample size994
Number of steps1
Drug
Study Staff
Type of cancerHead and Neck
Participating GroupsEORTC Radiation Oncology Group(Coordinating Group)
Protocol summaryCancer.gov (PDQ)
ClinicalTrials.gov
NCT number
EudraCT
@
Back to Protocol section